Abstract:171 Background: Along with genetic events, tumor associated epigenetic alterations including DNA methylation and post-translational histone modifications are important determinants in the initiation and progression of hepatocellular cancer (HCC) and represent promising biomarkers and therapeutic targets. Locus-specific trimethylation of histone H3 lysine 4 (H3K4me) is a well-known modification linked to the enhanced transcriptional expression of many genes activated in HCC. However its expression and association with prognosis of HCC patients remain unclear. Our aim was to assess the cellular expression pattern of H3K4me3 in HCC and its association with clinicopathologic variables and outcome. Methods: Expression of H3K4me3 and the histone methyltransferase SMYD3 was studied by western blotting and immunohistochemistry in human HCC cell lines and tumor tissue micmicroarray, which is from a well–characterized series of HCC patients(n=168). Tissue staining were assessed using blinded semiquantitative scoring. The optimal cut-point of H3K4me3 expression for prognosis was determined by the X-tile program. The prognostic significance was evaluated using Kaplan-Meier survival estimates and log-rank tests. Tumor tissue micmicroarray from another independent HCC patients cohort(n=147) was used for validation studies. Results: Expression of H3K4me3 and the histone methyltransferase SMYD3 were enhanced in HCC cell lines.In clinical tumor specimens, enhanced expression of H3K4me3 was correlated with reduced overall survival (P < 0.0001), especially in early-stage HCC patients(TNM I/II).Furthermore,both univariate and multivariate analysis revealed that H3K4me3 level was a significant and independent predictor of poor survival (hazard ratio,3.592; 95% CI, 2.302-5.605). In addition, H3K4m3 expression was positively correlated with SMYD3 expression in both testing and validation cohorts (P<0.0001). Conclusions: H3K4me3 level defines previously unrecognized subsets of HCC patients with distinct epigenetic phenotype and clinical outcome, thus can be a novel predictor for poor prognosis of HCC patients, especially within TNM I/IIstage.

Association between H3K4 methylation and cancer prognosis: A meta-analysis.

Association of High Histone H3k4 Trimethylation Level and Prognosis of Patients with Low-Tnm-Stage Hepatocellular Carcinoma.

The Methylation Modification of M6a Regulators Contributes to the Prognosis of Head and Neck Squamous Cell Carcinoma

High Expression of Trimethylated Histone H3 Lysine 4 is Associated with Poor Prognosis in Hepatocellular Carcinoma

The prognostic value of global DNA hypomethylation in cancer: a meta-analysis.

H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer

Association of H3K9me3 with breast cancer prognosis by estrogen receptor status

H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma As Epigenetic Markers.

Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer

The Association Between Methylation Patterns of DNAH17 and Clinicopathological Factors in Hepatocellular Carcinoma

High Level of H3K4 Tri-Methylation Modification Predicts Poor Prognosis in Esophageal Cancer

Prognostic Value of High EZH2 Expression in Patients with Different Types of Cancer: a Systematic Review with Meta-Analysis

Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis.

Meta-Analysis Of Dna Methylation Biomarkers In Hepatocellular Carcinoma

Combined Low Levels of H4K16ac and H4K20me3 Predicts Poor Prognosis in Breast Cancer.

Methylation Patterns of RASA3 Associated with Clinicopathological Factors in Hepatocellular Carcinoma.

The prognostic value of homeobox A9 (HOXA9) methylation in solid tumors: a systematic review and meta-analysis

The Expression and Significance of Histone Lysine Methylation in Endometrial Cancer.

Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis

High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1 (HIF-1) predict patients' worse prognosis in human hepatocellular carcinomas

Decreased Expression of H3K27me3 in Human Ovarian Carcinomas Correlates with More Aggressive Tumor Behavior and Poor Patient Survival.